Opthea Limited (OPT) Financials
OPT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 113.4 million | 145.4 million |
2023-06-30 | 65.4 million | 69.3 million |
2023-03-31 | 99.0 million | 104.9 million |
2022-12-31 | 104.9 million | 66.4 million |
OPT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -47.6 million | ? |
2023-06-30 | -33.5 million | 3.0 million |
2023-03-31 | -25.8 million | 1.5 million |
2022-12-31 | -47.1 million | 2.9 million |
OPT Net Income
No data available :(
OPT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 107.0 million | - | - |
2023-06-30 | 59.2 million | - | 120552 |
2023-03-31 | 89.5 million | - | - |
2022-12-31 | 96.6 million | - | 143492 |
OPT Shares Outstanding
OPT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 2922 | 58.1 million | - | - |
2023-06-30 | 9802 | 40.0 million | 13.1 million | 6.1 million |
2023-03-31 | 7495 | 30.5 million | 6.6 million | 1.4 million |
2022-12-31 | 4774 | 41.8 million | 14.6 million | 2.7 million |
OPT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 41745 | 35116 |
2023-06-30 | 37065 | 84869 |
2023-03-31 | 94467 | 42766 |
2022-12-31 | 35447 | 81668 |
OPT
Price: $3.28
52 week price:
Earnings Per Share: -2.41 USD
P/E Ratio: -1.22
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 800
Market Capitalization: 314.8 million